DAPA MET XR 10/500MG TAB

DAPA MET XR 10/500MG combines dapagliflozin and metformin HCL in an extended-release formulation designed to help manage type 2 diabetes. This dual-action tablet works by improving insulin sensitivity and reducing blood glucose levels through complementary mechanisms. Dapagliflozin helps the kidneys eliminate excess sugar through urine, while metformin reduces glucose production in the liver. Suitable for patients requiring combination therapy to achieve better glycemic control. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight.